[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-346713-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-346713-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","therapeutic-implications-of-targeting-cancer-testis-antigen-magea1-in-cervical-cancer","Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer","","MAGE family member A1 (MAGEA1) is a cancer-testis antigen expressed aberrantly in multiple malignancies, yet its significance in cervical cancer was unclear. This study assessed functional roles and therapeutic potential in cervical cancer using lentiviral short hairpin RNA knockdown, functional assays, RNA sequencing, and nude mouse xenograft models. MAGEA1 was upregulated, and silencing suppressed proliferation, migration, invasion, and in vivo tumor growth, while modulating apoptosis, DNA repair, and metabolism pathways. Knockdown also increased chemosensitivity, supporting MAGEA1 as an oncogenic driver, prognostic biomarker, and therapeutic target.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/therapeutic-implications-of-targeting-cancer-testis-antigen-magea1-in-cervical-cancer/346713/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/therapeutic-implications-of-targeting-cancer-testis-antigen-magea1-in-cervical-cancer/346713.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",7,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the main aim of targeting MAGEA1 in cervical cancer?","Question",{"text":63,"@type":64},"To determine the functional significance and therapeutic potential of MAGEA1 in cervical cancer using knockdown experiments and in vivo models.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How did MAGEA1 knockdown affect cervical cancer cells?",{"text":68,"@type":64},"Knockdown substantially suppressed cell proliferation, migration, invasion, and reduced in vivo tumor growth in nude mouse xenografts.",{"name":70,"@type":61,"acceptedAnswer":71},"Which molecular pathways were influenced after silencing MAGEA1?",{"text":72,"@type":64},"RNA-seq analysis indicated altered pathways related to apoptosis, DNA repair, and metabolism.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},346713,1790181890,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","INTERNATIONAL JOURNAL OF ONCOLOGY 68: 57, 2026  \nTherapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer  \nAYOUNG KIM 1,2* , JINAKIM 1,2* , WOORI KWAK 1,2* , KYUMIN MO 1,2 , SOOHYUN CHOE 1,2 , MINYEONG JEON 1,2 , JISUN LEE 1 , JUN‑WON YUN3 and HYUNHO YOON 1,2  \n1  \nDepartment of Medical and Biological Sciences, The Catholic University of Korea, Bucheon, Gyeonggi 14662, Republic of Korea; 2  \nDepartment of Biotechnology, The Catholic University of Korea, Bucheon, Gyeonggi 14662, Republic of Korea; 3  \nLaboratory of Veterinary Toxicology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, Seoul 08826, Republic of Korea  \nReceived June 16, 2025; Accepted January 20, 2026  \nDOI: 10.3892/ijo.2026.5870  \nAbstract . MAGE family member A1 (MAGEA1), a cancer‑testis antigen (CTA), is aberrantly expressed in several malignancies such as lung and liver cancers . However, its role in cervical cancer remains to be elucidated. The present study investigated the functional significance and therapeutic potential of MAGEA1 in cervical cancer using lentiviral short hairpin RNA‑mediated knockdown, a series of functional assays, RNA sequencing (RNA‑seq), and nude mouse xeno‑ graft models. It was found that MAGEA1 was upregulated in cervical cancer cells and its knockdown substantially suppressed cell proliferation, migration, invasion, and in vivo tumor growth. RNA‑seq analysis further revealed that MAGEA1 silencing altered pathways related to apoptosis, DNA repair, and metabolism . Moreover, MAGEA1 knock‑ down enhanced chemosensitivity, indicating a potential role in mediating drug resistance. Collectively, the findings identified MAGEA1 as a key oncogenic driver in cervical cancer and highlighted its promise as both a prognostic biomarker anda therapeutic target, offering novel avenues for personalized treatment strategies in cervical cancer.  \nCorrespondence to: Professor Jun‑Won Yun, Laboratory of Veterinary Toxicology, College of Veterinary Medicine and Research Institute for Veterinary Science, Seoul National University, 1 Gwanak‑ro, Gwanak, Seoul 08826, Republic of Korea  \nE‑mail: [jwyun@snu.ac.kr](jwyun@snu.ac.kr)  \nProfessor Hyunho Yoon, Department of Medical and Biological Sciences, The Catholic University of Korea, 43 Jibong‑ro, Wonmi, Bucheon, Gyeonggi 14662, Republic of Korea  \nE‑[mail: hyoon@catholic.ac.kr](mail: hyoon@catholic.ac.kr)[ ](mail: hyoon@catholic.ac.kr)*Contributed equally  \nKey words: cancer testis antigen, MAGE family member A1, oncogene, cervical cancer, biomarker  \nIntroduction  \nCervical cancer is one of the most common gynecological carcinomas in the world with 569,847 cases and 311,365 mortalities annually (1) . It ranks the second most prevalent lethal tumors in developing countries and the tenth in devel‑ oped countries; in 2020, ~600,000 women were diagnosed with invasive cervical cancer, mostly in advanced stages (2) . The World Health Organization (WHO) announced cervical cancer as a public health problem in May 2018. Cervical cancer is classified into two histological subtypes including squamous cell carcinoma (SCC) and adenocarcinoma (ADC) accounting for 68 and 21%, respectively. These two subtypes have different features in accordance with etiology, screening effectiveness, and prognosis (3) . Accumulated studies have suggested that ADC exhibits worse prognosis compared with SCC (4) . The major risk factors related to cervical cancer involve persistent human papilloma virus (HPV) infection, smoking, presence of sexual transmitted disease, such as human immunodeficiency virus or chlamydia infection (5) . Despite early screening and vaccination, it remains the second leading cause of mortality in women aged 20‑39 (6) . There are critical individual differences in the prognosis of patients because of tumor heterogeneity. Thus, it is essen‑ tial to investigate molecular heterogeneity and establish a complete prognostic assessmen","cbCaiplFrLGV8maM","https://ap.wps.com/l/cbCaiplFrLGV8maM","pdf",9529193,13,"English","# Abstract\n# Introduction\n## Background on cervical cancer\n## Cancer-testis antigens and CTAs\n## MAGE family overview","[{\"question\":\"What was the main aim of targeting MAGEA1 in cervical cancer?\",\"answer\":\"To determine the functional significance and therapeutic potential of MAGEA1 in cervical cancer using knockdown experiments and in vivo models.\"},{\"question\":\"How did MAGEA1 knockdown affect cervical cancer cells?\",\"answer\":\"Knockdown substantially suppressed cell proliferation, migration, invasion, and reduced in vivo tumor growth in nude mouse xenografts.\"},{\"question\":\"Which molecular pathways were influenced after silencing MAGEA1?\",\"answer\":\"RNA-seq analysis indicated altered pathways related to apoptosis, DNA repair, and metabolism.\"}]","Therapeutic implications of targeting cancer testis antigen MAGEA1 in cervical cancer | PDF",1790062500,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc8250a3f9619c01af1ce470d91f8f11.webp",983,1357,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8566bd03e2b10be78334fb34ec9874b9.webp",982,1356,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/288d5733ce72ac09263678e6fe0b60d0.webp",981,1354,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/56dc6e6a545be502da8c859d69c79384.webp",980,1353]